Published in Kidney Int on September 01, 1987
In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. Kidney Int (2009) 2.09
Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets. J Biol Chem (2013) 1.14
Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl. J Clin Invest (1996) 1.09
Cholesterol Metabolism in CKD. Am J Kidney Dis (2015) 0.84
Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production. Transl Res (2012) 0.83
Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. J Diabetes Complications (2013) 0.75
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation (2000) 2.47
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation (1993) 2.04
A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest (1969) 1.93
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation (1990) 1.89
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med (1993) 1.82
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest (1985) 1.79
Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta (1972) 1.73
Mutagenesis and mapping of the gene for a sporulation-specific penicillin-binding protein in Bacillus subtilis. J Bacteriol (1992) 1.69
Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med (1982) 1.67
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis (1982) 1.45
Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med (1996) 1.43
Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron (1993) 1.42
Degradative effect of phenol on endotoxin and lipopolysaccharide preparations from Serratia marcescens. J Bacteriol (1974) 1.39
Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial. Circulation (1995) 1.38
Lipoprotein metabolism and renal failure. Am J Kidney Dis (1993) 1.37
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant (1997) 1.33
Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N Engl J Med (1978) 1.23
Correlation between ultrasoundcardiography, hemodynamics and surgical findings in mitral stenosis. Am J Cardiol (1967) 1.21
Apoliproproteins and lipoproteins. Atherosclerosis (1971) 1.17
Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res (1989) 1.17
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol Dial Transplant (1994) 1.17
Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. Clin Chem (1976) 1.15
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation (1994) 1.14
Clinical and hip simulator comparisons of ceramic-on-polyethylene and metal-on-polyethylene wear. Clin Orthop Relat Res (2000) 1.14
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest (1981) 1.14
Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett (1973) 1.13
Studies of the composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma. Biochemistry (1970) 1.12
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens 08. Biochemistry (1973) 1.11
Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet (1981) 1.10
Adipose tissue fat cell size and number in relation to metabolism in endogenous hypertriglyceridemia. Acta Med Scand (1971) 1.08
Determination of human apolipoprotein E by electroimmunoassay. Biochim Biophys Acta (1976) 1.06
Metal-on-metal bearing in hip prosthesis generates 100-fold less wear debris than metal-on-polyethylene. Acta Orthop Scand (1999) 1.06
Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma. Biochemistry (1972) 1.05
The differential diagnosis of neonatal hepatitis and biliary atresia. J Pediatr Surg (1974) 1.04
A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest (1970) 1.04
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res (1983) 1.03
Studies on the characterization of lipopolysaccharides from two strains of Serratia marcescens. Ann N Y Acad Sci (1966) 1.03
Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Nephron (1991) 1.02
Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: clinical aspects. Clin Cardiol (1999) 1.02
Studies of the composition and structure of serum lipoproteins. Separation and characterization of phospholipid-protein residues obtained by partial delipidization of very low density lipoproteins of human serum. Biochemistry (1966) 1.02
Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim Biophys Acta (1980) 1.02
Acute determination of plasma glycerol as a means of predicting arrhythmias in patients with myocardial ischaemia. Br Heart J (1974) 1.01
Gonadal steroid effects on plasma lipoproteins and individual phospholipids. J Clin Endocrinol Metab (1972) 1.01
Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J Clin Invest (1984) 1.00
Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. Biochemistry (1978) 1.00
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens Bizio. Biochemistry (1973) 0.99
Carbohydrate and lipid metabolism in middle-aged, physically well-trained men. Metabolism (1972) 0.98
Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes. Biochim Biophys Acta (1987) 0.98
Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem (1978) 0.98
Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma. Biochemistry (1976) 0.97
Effects of medium chain length triglyceride (MCT) on serum lipids and lipoproteins in familial hyperchylomicronemia (dietary fat-induced lipemia) and dietary carbohydrate-accentuated lipemia. J Lab Clin Med (1965) 0.95
Cardaic arrhythmias in chloral hydrate poisoning. Acta Med Scand (1977) 0.93
Quantitative determination of human apolipoprotein D by electroimmunoassay and radial immunodiffusion. Biochim Biophys Acta (1977) 0.93
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol (1998) 0.92
David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins. Can J Biochem (1981) 0.92
Physiocochemical properties of low-density lipoproteins of normal human plasma. Evidence for the occurrence of lipoprotein B in associated and free forms. Biochem J (1974) 0.91
Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate. Arterioscler Thromb Vasc Biol (1997) 0.91
Effects of saturated, monounsaturated, and omega-6 polyunsaturated fatty acids on plasma lipids, lipoproteins, and apoproteins in humans. Am J Clin Nutr (1983) 0.91
Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Atherosclerosis (1981) 0.91
Plasma lipids and apolipoproteins in a 13-year-old boy with diabetic ketoacidosis and extreme hyperlipidemia. Am J Med Sci (1986) 0.90
Reduced high density lipoproteins as a risk factor after acute myocardial infarction. Acta Med Scand (1987) 0.90
Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. Atherosclerosis (1980) 0.90
Binding and degradation of human high-density lipoproteins by human hepatoma cell line HepG2. Biochim Biophys Acta (1985) 0.90
Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay. Clin Chem (1987) 0.89
Studies in cholestasis of pregnancy. I. Clinical aspects and liver function tests. Acta Obstet Gynecol Scand (1975) 0.89
Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells. J Lipid Res (1990) 0.89
Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiency. Scand J Clin Lab Invest (1979) 0.88
Catabolism of human low density lipoproteins by human hepatoma cell line HepG2. Biochim Biophys Acta (1984) 0.88
Differential activation of lipoprotein lipase from human post-heparin plasma, milk and adipose tissue by polypeptides of human serum Apolipoprotein C. FEBS Lett (1971) 0.88
Isolation and characterization of human chyle chylomicrons and lipoproteins. Ann N Y Acad Sci (1968) 0.88
Determination of serum lipoprotein-X for the early differentiation between neonatal hepatitis and biliary atresia. J Surg Res (1975) 0.87
Nutrition in low-birth-weight infants. I. Intravenous injection of fat emulsion. Acta Paediatr Scand (1972) 0.87
Nutrition in low-birth-weight infants. II. Repeated intravenous injections of fat emulsion. Acta Paediatr Scand (1974) 0.87
Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels. Atherosclerosis (1989) 0.87
The compositional abnormalities of lipoproteins in diabetic renal failure. Nephrol Dial Transplant (1998) 0.86
Glyceraldehyde-3-phosphate dehydrogenase from human erythrocyte membranes. Kinetic mechanism and competitive substrate inhibition by glyceraldehyde 3-phosphate. Arch Biochem Biophys (1980) 0.85
Treatment of hyperlipoproteinemia (HLP) type II A with a new phenoxy-isobuturic acid derivative, procetofen. Int J Clin Pharmacol Biopharm (1979) 0.85
Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays. Clin Chem (1981) 0.85
Left atrial myxoma diagnosed by ultrasound cardiography. Angiology (1973) 0.85
Plasma lipid and apolipoprotein profiles of women with two types of peripheral arterial disease. Atherosclerosis (1984) 0.85
Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance. Am J Obstet Gynecol (1992) 0.85
Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency. Atherosclerosis (1982) 0.85
Third-body abrasive wear challenge of 32 mm conventional and 44 mm highly crosslinked polyethylene liners in a hip simulator model. Proc Inst Mech Eng H (2009) 0.85
Mapping of the gene for a major penicillin-binding protein to a genetically conserved region of the Bacillus subtilis chromosome and conservation of the protein among related species of Bacillus. J Bacteriol (1991) 0.84
Polyunsaturated fatty acids in hyperlipoproteinemia. I. Influences of a sucrose-rich diet on fatty acid composition of serum lipoprotein lipids. Nutr Metab (1974) 0.84
Effects induced by two different estrogens on serum individual phospholipids and serum lecithin fatty acid composition. Horm Metab Res (1981) 0.84
Serum lipoprotein deficiency in diffuse "normolipemic" plane xanthoma. Arch Dermatol (1972) 0.84
Ultracentrifugal characterization of a lipoprotein occurring in obstructive jaundice. Clin Chim Acta (1969) 0.84
Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Kidney Int (1999) 0.84
Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma. Biochemistry (1982) 0.84
Lipid transport in the avian species. Part I. Isolation and characterization of apolipoproteins and major lipoprotein density classes of male turkey serum. Atherosclerosis (1976) 0.84
Dyslipidemia in peritoneal dialysis--relation to dialytic variables. Perit Dial Int (2000) 0.84
Hip-simulator ranking of polyethylene wear: comparisons between ceramic heads of different sizes. Acta Orthop Scand (1996) 0.83
Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension. Am J Ther (1999) 0.83